Pitch for Investment

Latest Insights, Interviews, News, and Resources.

The latest news from UKI2S and our portfolio companies

Lab work

SynbiCITE’s 4-day MBA: Advancing the next generation of engineering biology companies

29th July 2019

SynbiCITE, the UK’s national centre for the commercialisation of engineering biology, is powering the engineering biology industry, applying lab-based R&D…
Discussion on technology & innovation at SynbiTECH 2019

SynbiTECH 2019: Innovation, Investment and the Engineering Biology Revolution

17th July 2019

Oliver Sexton, Investment Director, and Pablo Lubroth, Investment Manager, UKI2S, share their thoughts on the recent SynbiTECH2019 conference in London.
Mark White

Can SME’s work with utilities and find a way to market?

4th July 2019

Engineering technology innovators Oxford Flow and Utonomy are testing new products to improve the gas distribution network.
Andrew Muir

BBSRC Awards bust the UK’s innovation myth

25th June 2019

The UK is good at research, but poor at innovation. That’s a common view among policymakers, but an out-dated one, argues Andy Muir from the UK Innovation & Science Seed Fund who recently judged…
Cytoseek wins Rising Star Award

CytoSeek Wins at Launch: Great West Rising Star Award

19th June 2019

UKI2S would like to congratulate CytoSeek on winning the Rising Star Award at the 1st annual Launch: Great West awards.
Quethera leaderships wins BVCA Management Team Award

Former Quethera leadership wins BVCA Management Team Award

14th June 2019

UKI2S congratulates the former management team of Quethera led by CEO Dr. Peter Widdowson and CSO Professor Keith Martin as winners of the British Venture Capital Association Management Team Award.
Seedlings

Synthace share the secrets of successful seed funding

22nd May 2019

Innovative software company Synthace is working to transform the way that scientists and companies do biology.
microbiome

CHAIN Appoints New Non-Executive Directors

10th April 2019

UK microbiome therapeutics company CHAIN Biotechnology has appointed two new non-executive directors, Dr Nel Moore and Dr Robert Haigh to the Board.
Trophy

Crescendo Biologics wins in “Life Science Innovation” category at the Business Weekly Awards 2019

22nd March 2019

The drug developer of novel, targeted T-cell enhancing therapeutics, announces winning the award for “Life Science Innovation” at the Business Weekly Awards 2019.
Working

UKI2S AND INNOVATE UK LAUNCH NEW £10M INITIATIVE TO ACCELERATE GROWTH OF EARLY STAGE SCIENCE AND ENGINEERING COMPANIES

21st March 2019

UK Innovation & Science Seed Fund (UKI2S) and Innovate UK (IUK) have launched a joint initiative, the UKI2S Innovate Accelerator.
ATELERIX LTD

Atelerix Raises Follow-on Funding Round of £700,000

9th March 2019

Cell encapsulation for transport of cells and tissues at room temperature.
DNA

Life, but not as you know it

25th February 2019

The DNA alphabet just doubled in size. Steven Benner at the Foundation for Applied Molecular Evolution in Florida has published two new functional, artificial nucleobases.
Scientific Research

EPSRC Announces £440m for Doctoral Training

15th February 2019

Funding for 75 Centres for Doctoral Training (CDTs) under the umbrella of the Engineering and Physical Sciences Research Council (EPSRC) was announced last week.
Crescendo

Eagle Genomics Closes $3.5M Investment

30th January 2019

Microbiome discovery platform company Eagle Genomics announces funding of $3.5M led by the Environmental Technologies Fund (ETF Partners), a European growth fund specialising in promoting sustainability through innovation.
Brain

Tech to Watch 2019 – AI

24th January 2019

Artificial Intelligence, or machine learning, is steadily working its way into our lives. Businesses are increasingly confident of using AI to increase customer engagement with giants Microsoft, Apple, Google and Amazon leading the charge.
microbes

Tech to Watch 2019 – The Microbiome

9th January 2019

The relationship between human health and the microbes that live on and within us (our microbiome) is increasingly understood, particularly for the microbes…
Medication

Eastern Biopharma Industry and Investment

20th December 2018

The BioCentury China Healthcare Summit saw thought leaders from industry, academia and finance meet in Shanghai to learn about China’s burgeoning biopharma ecosystem.
Newspaper

December UKI2S Digest

13th December 2018

Headlines: CRISPR Ethics. Life Science Sector Deal Announced…
Lab work

Crescendo Biologics lives up to its name

22nd November 2018

UKI2S has privileged access to emerging research across many of the UK’s science and technology campuses.
Tokamak Fusion Energy

Funding Boost for Fusion

15th November 2018

Nuclear fusion has long held the promise of cheap, plentiful and, above all, clean energy with zero carbon emissions and minimal radiation issues that undermine public confidence in nuclear fission.

Production

UKI2S Synbio Digest

5th November 2018

Synbio Digest features news, views and reports covering the engineering biology industry and recent research.
Quethera funding story

A Fork in the Road: Quethera’s Story

23rd October 2018

UKI2S announced in August the successful exit of its portfolio company Quethera. Acquired by Japanese pharma giant Astellas for up to £85 million, the deal…
Scientist

Microsoft Genomics ventures into the microbiome with Eagle Genomics

16th October 2018

Read the full press release here…
Tropic Biosciences are preventing banana extinction

The Banana is dying out. The race is on to reinvent it before it’s too late

12th October 2018

The world’s most popular fruit is facing extinction, and scientists are racing to use gene-editing to save it. To succeed, they’ll need to overcome an even bigger problem: opposition to GMO crops.
UKI2S

© UKI2S and Future Planet Capital (Ventures) Limited. All Rights Reserved. UKI2S is managed by Future Planet Capital (Ventures) Limited which is Authorised and Regulated in the UK by the Financial Conduct Authority FRN 148549. Registered in England and Wales. Company Number 2500898. Registered Address: Future Planet Capital (Ventures) Limited, 1 Scott Place, 2 Hardman Street, Manchester, M3 3AA.

Stay updated

UKI2S
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.